Welcome

The discovery of microRNA is often mentioned as the most important breakthrough in molecular biology during the last decade. MicroRNAs are powerful cellular regulators that play a role in most cellular processes and microRNA regulatory pathways are promising targets for the development of new therapeutics.

Mirrx Therapeutics A/S holds fundamental IP to a unique technology for modulation of microRNA regulatory pathways. The so-called Blockmir compounds developed by Mirrx have relevance for all major disease areas and reduce risks of unwanted side-effects dramatically, compared to other compounds that interfere with the microRNA pathways.